Thermo Fisher Scientific Inc. (TMO)

Historical Portfolio Holders from 2014 to 2024

All holders as of
Q1 2024
Type / Class
Equity / COM
Shares, Excl. Options Q1 2024
$314M
Holdings value Q1 2024
$182B
Value change Q1 2024
-$4.68B
Grand Portfolio weight change Q1 2024
-0.01%
Number of holders
2495
Number of Buys Q1 2024
1104
Number of Sells Q1 2024
-1021
Average Buys Q1 2024 %
+0.083%
Average Sells Q1 2024 %
-0.023%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Filings
Period Shares, Excl. Options Value, Excl. Options Change Price Filings
2024 Q1 312M $181B -$4.43B $581.21 2,416
2023 Q4 327M $174B +$2.5B $530.79 2,484
2023 Q3 333M $168B +$1.22B $506.17 2,367
2023 Q2 336M $173B -$190M $521.75 2,406
2023 Q1 331M $191B -$1.8B $576.37 2,392
2022 Q4 343M $190B +$1.32B $550.69 2,406
2022 Q3 343M $174B -$73.9M $507.19 2,288
2022 Q2 341M $185B +$694M $543.28 2,302
2022 Q1 343M $202B -$80.4M $590.65 2,337
2021 Q4 343M $229B +$304M $667.24 2,371
2021 Q3 343M $196B +$1.8B $571.33 2,166
2021 Q2 340M $172B -$330M $504.47 2,108
2021 Q1 342M $156B -$1.28B $456.38 2,069
2020 Q4 348M $162B -$1.4B $465.78 2,068
2020 Q3 351M $155B -$928M $441.52 1,879
2020 Q2 353M $128B -$48.5M $362.34 1,774
2020 Q1 350M $99.4B -$817M $283.60 1,701
2019 Q4 356M $115B -$349M $324.87 1,713
2019 Q3 357M $104B +$691M $291.27 1,582
2019 Q2 356M $105B +$2.55B $293.68 1,594
2019 Q1 355M $97.2B +$1.46B $273.72 1,564
2018 Q4 353M $78.9B -$145M $223.79 1,494
2018 Q3 354M $86.5B +$1.24B $244.08 1,390
2018 Q2 351M $72.6B +$1.2B $207.14 1,353
2018 Q1 351M $72.3B -$319M $206.46 1,342
2017 Q4 353M $67B +$685M $189.88 1,280
2017 Q3 350M $66.2B +$2.75B $189.20 1,197
2017 Q2 338M $59B -$91.1M $174.47 1,192
2017 Q1 343M $52.7B +$3.38B $153.60 1,166
2016 Q4 344M $48.5B -$46.4M $141.10 1,151
2016 Q3 349M $55.1B -$199M $159.06 1,075
2016 Q2 348M $51.3B -$1.73B $147.76 1,084
2016 Q1 361M $49.2B -$652M $141.59 1,048
2015 Q4 355M $50.4B +$494M $141.85 1,055
2015 Q3 358M $43.8B +$1.13B $122.28 997
2015 Q2 353M $45.2B +$3.39M $129.76 1,005
2015 Q1 358M $48B -$233M $134.34 995
2014 Q4 363M $45.5B +$697M $125.29 994
2014 Q3 362M $44.1B +$342M $121.70 949
2014 Q2 366M $43.2B +$906M $118.00 940
2014 Q1 362M $43.5B +$915M $120.24 951